Medicare Enrolled
Dr. Jeffrey Lin, D.O.
Infectious Disease · Fort Walton Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lin
Dr. Jeffrey Lin is an infectious disease specialist in Fort Walton Beach, FL, with 9 years of NPI registration. Based on federal Medicare data, Dr. Lin performed 2,121,542 Medicare services across 4,519 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lin received a total of $5,880 from 17 pharmaceutical and/or device companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 0% volume in FL
$5,880 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 17605 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗2,121,542
Medicare services
Top 0% in FL for infectious disease
4,519
Unique beneficiaries
$1
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~235,727 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 1,950,774 | $0 | $0 |
| Injection, omadacycline, 1 mg | 105,509 | $3 | $8 |
| Oritavancin antibiotic injection, 10 mg This procedure involves the administration of a 10 mg dose of oritavancin, an antibiotic medication, via injection. |
19,080 | $32 | $113 |
| Injection, meropenem, 100 mg | 8,545 | $0 | $3 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
6,993 | $0 | $12 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
5,740 | $11 | $65 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
5,144 | $48 | $176 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,947 | $62 | $223 |
| Injection, cefepime hydrochloride, 500 mg | 2,930 | $1 | $4 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
2,137 | $22 | $82 |
| Denosumab injection (Prolia/Xgeva) | 1,680 | $18 | $66 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
1,467 | $15 | $56 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
957 | $94 | $323 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
924 | $96 | $355 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
786 | $138 | $493 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
781 | $137 | $496 |
| Anti-nausea injection (ondansetron/Zofran) | 775 | $0 | $0 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
558 | $12 | $50 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
532 | $170 | $509 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
481 | $98 | $365 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
468 | $1 | $3 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
430 | $1 | $8 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
426 | $3 | $10 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
315 | $10 | $35 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
274 | $18 | $42 |
| Wound tissue removal, 20 sq cm or less This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less. |
245 | $77 | $232 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
173 | $25 | $103 |
| New patient office visit, complex (60-74 min) | 140 | $162 | $615 |
| Injection, furosemide, up to 20 mg | 66 | $0 | $6 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
60 | $11 | $37 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
54 | $16 | $59 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
39 | $6 | $6 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
32 | $32 | $123 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
26 | $59 | $228 |
| Infusion tube insertion with imaging guidance A radiologist inserts an infusion tube into the body while using imaging guidance to ensure proper placement and reviews the procedure. |
25 | $294 | $811 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $126 | $433 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
12 | $40 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
99.2% medium
0.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,880
Total received (2021-2024)
Avg $1,470/year across 4 years
Top 20% in FL for infectious disease
17
Companies
100
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,261 (72.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,619 (27.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,633
2023
$487
2022
$582
2021
$178
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Melinta Therapeutics, LLC
$4,261
Paratek Pharmaceuticals, Inc.
$538
ABBVIE INC.
$264
La Jolla Pharmaceutical Company
$123
Merck Sharp & Dohme LLC
$118
Ferring Pharmaceuticals Inc.
$104
ViiV Healthcare Company
$85
Amgen Inc.
$83
AstraZeneca Pharmaceuticals LP
$79
Gilead Sciences, Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$37
Invivyd Inc
$32
Insmed, Inc.
$27
ConvaTec Inc.
$26
Octapharma USA, Inc.
$21
Philips North America LLC
$18
Averitas Pharma Inc.
$17
Top 3 companies account for 86.1% of total payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · APRETUDE · AVYCAZ · Arikayce · CABENUVA · DALVANCE · DIFICID · DOVATO · EVENITY · EVUSHELD · GLASSIA · INNOVAMATRIX AC · KRYSTEXXA · Kimyrsa · MAVYRET · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · PEMGARDA · QUTENZA · REBYOTA · TEFLARO · XERAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $0 per 100 Medicare services performed
Geographic Context
Infectious diseases within 10 mi
6
Per 100K population
2.8
County median income
$79,097
Nearest hospital
HCA FLORIDA FORT WALTON-DESTIN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lin is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with speaking/promotional industry engagement in the top 20% of FL peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lin experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Lin performed 1,950,774 daptomycin antibiotic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $5,880 from 17 companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lin's costs compare to other infectious diseases in Fort Walton Beach?
Dr. Lin's average Medicare payment per service is $1. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Fort Walton Beach
Browse infectious diseases in Fort Walton Beach ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in FL
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in FL
Which FL infectious diseases receive the most from drug and device companies.
By company
Melinta Therapeutics, LLC Payments to Doctors
See all physicians who received payments from Melinta Therapeutics, LLC.
By company
Paratek Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Paratek Pharmaceuticals, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology